FDA.reportPublic FDA data

Application 210786

Type
ANDA
Sponsor
NOVAST LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NADOLOLNADOLOLTABLET;ORAL20MGNoNo
002NADOLOLNADOLOLTABLET;ORAL40MGNoNo
003NADOLOLNADOLOLTABLET;ORAL80MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50742-178NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-178NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-178NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-179NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-179NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-179NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-180NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-180NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent
50742-180NADOLOLnadololIngenus Pharmaceuticals, LLCANDACurrent